I am very surprised with this IPO allotment. Those people applied 5250 shares they not got allotment and those people applied 1050 shares they got allotment 350 shares. I applied 3500 shares I got nil. Some examples I giving you bellow:
Company Name: MEGHMANI ORGANICS LIMITED Application no.24730979 Sole / 1st Applicant: deepak mehta Cut off Price: 19 Shares applied: 5250
Allotment Details Shares Allotted: nil
Company Name: MEGHMANI ORGANICS LIMITED Application no.24731098 Sole / 1st Applicant: rajendrakumar kantibhai patel Cut off Price: 19 Shares applied: 2450
Allotment Details Shares Allotted: 350
Company Name: MEGHMANI ORGANICS LIMITED Application no. 24731095 Sole / 1st Applicant: manjusha ashok patel Cut off Price: 19 Shares applied: 1400
Allotment Details Shares Allotted: 350
Company Name: MEGHMANI ORGANICS LIMITED Application no. 24730765 Sole / 1st Applicant: sanjeev kumar bakshi Cut off Price: 19 Shares applied: 1050
Hi all I applied for 1400 shares, i didn't get anything.
You can verify your application status from the following link. http://www.intimespectrum.com/site/ipo.asp Click on "Check application status" then enter your application number
Hi Smart I spoke to intimespectrum (callcentre executive) ,regardingallotment aginst application, enquired regarding listing date and refund of funds. Probable listing date - 28 Jun Refund of funds - within 4-5 days (from today)
meghamni will list at about 25 but will come down very sharply in few days.will reach 14-15 rs in 1 week. as mention in icici review this stock looks overpriced as chemical industry do not command high p/e.see i am holding gwalior chemical which went up on listing but crashed later.
at the lower price of rs 17, the issue is valued at a p/e multiple of 8.24x its diluted fy08e eps of rs 2.06. at the upper end of the band of rs 19, the issue is valued at 8.98x its diluted fy08e eps of rs 2.12. the issue looks expensive compared to peers like rallis india and shreyas intermediate, which are currently trading at a lower p/e to their fy08e eps. on an ev/ ebidta basis, the stock also looks overpriced. established companies are available at cheaper valuations. we believe investors should avoid the issue.